Skip to main content

Lee Sung's Form 4 filing

Cytokinetics Inc (CYTK) · filed Jun 29, 2026

Accession no.
0001061983-26-000071
Filed
Jun 29, 2026
Trade date
Jun 24, 2026
Filing delay
5 daysLate
Rule 10b5-1 plan
Checked

This filing lists 8 non-derivative transactions and 7 derivative transactions. Open-market sales total $3.19M. It was filed 5 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lee SungCIK 0001793200Officer (EVP, Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 24, 2026Common StockMOption exerciseAcquired+23,370$48.51+$1,133,678.786,591Direct
Jun 24, 2026Common StockMOption exerciseAcquired+9,307$44.36+$412,858.5295,898Direct
Jun 24, 2026Common StockMOption exerciseAcquired+2,817$44.36+$124,962.1298,715Direct
Jun 24, 2026Common StockMOption exerciseAcquired+1,113$48.51+$53,991.6399,828Direct
Jun 24, 2026Common StockMOption exerciseAcquired+188$44.36+$8,339.68100,016Direct
Jun 24, 2026Common StockMOption exerciseAcquired+822$44.36+$36,463.92100,838Direct
Jun 24, 2026Common StockMOption exerciseAcquired+1,113$48.51+$53,991.63101,951Direct
Jun 24, 2026Common StockSSaleDisposed−38,730$82.30−$3,187,47963,221Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 24, 2026Common StockMOption exerciseDisposed−23,370$0.00$030,047Direct
Jun 24, 2026Common StockMOption exerciseDisposed−9,307$0.00$032,019Direct
Jun 24, 2026Common StockMOption exerciseDisposed−2,817$0.00$06,199Direct
Jun 24, 2026Common StockMOption exerciseDisposed−1,113$0.00$028,934Direct
Jun 24, 2026Common StockMOption exerciseDisposed−188$0.00$06,011Direct
Jun 24, 2026Common StockMOption exerciseDisposed−822$0.00$031,197Direct
Jun 24, 2026Common StockMOption exerciseDisposed−1,113$0.00$027,821Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)